Henny H. Billett

Henny H. Billett

Hematology

60 East 208th Street
Bronx, NY 10467

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Sickle cell disease 115 years later: improving health outcomes through policy, research, and collaboration, to achieve health equity.

Sickle cell disease 115 years later: improving health outcomes through policy, research, and collaboration, to achieve health equity.

Journal: Frontiers in health services

Published: March 29, 2026

Dose-reduced apixaban for secondary prophylaxis in patients with severe obesity: a single center analysis.

Dose-reduced apixaban for secondary prophylaxis in patients with severe obesity: a single center analysis.

Journal: Blood advances

Published: January 29, 2025

Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714].

Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714].

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 21, 2024

Splenomegaly and Response to Splenectomy in Immune Thrombocytopenia.

Splenomegaly and Response to Splenectomy in Immune Thrombocytopenia.

Journal: Journal of clinical medicine

Published: May 09, 2024

Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study.

Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study.

Journal: Annals of hematology

Published: March 20, 2024

Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.

Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 12, 2023

Venous thromboembolism prophylaxis practices for patients with sickle cell disease prior to and during the COVID-19 pandemic.

Venous thromboembolism prophylaxis practices for patients with sickle cell disease prior to and during the COVID-19 pandemic.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: September 27, 2023

Diagnosing TMAs by automated red cell morphology analyses.

Diagnosing TMAs by automated red cell morphology analyses.

Journal: Blood advances

Published: August 14, 2023

Identifying Neutrophil Extracellular Traps (NETs) in Blood Samples Using Peripheral Smear Autoanalyzers.

Identifying Neutrophil Extracellular Traps (NETs) in Blood Samples Using Peripheral Smear Autoanalyzers.

Journal: Life (Basel, Switzerland)

Published: February 08, 2023

The role of immune status, viral co-infections and paraproteinemia in development of venous thromboembolism in HIV.

The role of immune status, viral co-infections and paraproteinemia in development of venous thromboembolism in HIV.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: November 21, 2022

Outcomes With Direct and Indirect Thrombin Inhibition During Extracorporeal Membrane Oxygenation for COVID-19.

Outcomes With Direct and Indirect Thrombin Inhibition During Extracorporeal Membrane Oxygenation for COVID-19.

Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)

Published: June 07, 2022

Direct oral Xa inhibitors for the treatment of venous thromboembolism after bariatric surgery.

Direct oral Xa inhibitors for the treatment of venous thromboembolism after bariatric surgery.

Journal: Blood advances

Published: November 24, 2021

Showing 1-12 of 62

Last Updated: 09/26/2026